Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

Lee H, Kim KR, Noh SJ, Park HS, Kwon KS, Park BH, Jung SH, Youn HJ, Lee BK, Chung MJ, Koh DH, Moon WS, Jang KY.

Hum Pathol. 2011 Feb;42(2):204-13. doi: 10.1016/j.humpath.2010.05.023. Epub 2010 Nov 5.

PMID:
21056897
[PubMed - indexed for MEDLINE]
2.

Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.

Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, Moon WS, Jang KY.

Clin Cancer Res. 2009 Jul 1;15(13):4453-9. doi: 10.1158/1078-0432.CCR-08-3329. Epub 2009 Jun 9.

PMID:
19509139
[PubMed - indexed for MEDLINE]
Free Article
3.

Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.

Noh SJ, Kang MJ, Kim KM, Bae JS, Park HS, Moon WS, Chung MJ, Lee H, Lee DG, Jang KY.

Pathology. 2013 Oct;45(6):574-80. doi: 10.1097/PAT.0b013e3283652c7a.

PMID:
24018803
[PubMed - indexed for MEDLINE]
4.

Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.

Guarneri V, Barbieri E, Piacentini F, Giovannelli S, Ficarra G, Frassoldati A, Maiorana A, D'Amico R, Conte P.

Int J Biol Markers. 2010 Apr-Jun;25(2):104-11.

PMID:
20544688
[PubMed - indexed for MEDLINE]
5.

Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.

Kim JR, Moon YJ, Kwon KS, Bae JS, Wagle S, Yu TK, Kim KM, Park HS, Lee JH, Moon WS, Lee H, Chung MJ, Jang KY.

PLoS One. 2013 Sep 3;8(9):e74738. doi: 10.1371/journal.pone.0074738. eCollection 2013.

PMID:
24019980
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Balance between SIRT1 and DBC1 expression is lost in breast cancer.

Sung JY, Kim R, Kim JE, Lee J.

Cancer Sci. 2010 Jul;101(7):1738-44. doi: 10.1111/j.1349-7006.2010.01573.x. Epub 2010 Mar 24.

PMID:
20412117
[PubMed - indexed for MEDLINE]
7.

The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

Kim SH, Kim JH, Yu EJ, Lee KW, Park CK.

Histol Histopathol. 2012 Jan;27(1):49-58.

PMID:
22127596
[PubMed - indexed for MEDLINE]
8.

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.

Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.

J Am Coll Surg. 2004 Jan;198(1):83-90.

PMID:
14698315
[PubMed - indexed for MEDLINE]
9.

Expression of BRCA1 protein in breast cancer and its prognostic significance.

Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO.

Hum Pathol. 2008 Jun;39(6):857-65. doi: 10.1016/j.humpath.2007.10.011. Epub 2008 Apr 8.

PMID:
18400253
[PubMed - indexed for MEDLINE]
10.

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.

Croat Med J. 2006 Feb;47(1):32-41.

PMID:
16489695
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.

Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, Kong Y, Lv N, Jia W, Zhang Y, Xie X.

Med Oncol. 2012 Dec;29(5):3240-9. doi: 10.1007/s12032-012-0260-6. Epub 2012 Jun 4.

PMID:
22661383
[PubMed - indexed for MEDLINE]
12.

FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.

PMID:
17671124
[PubMed - indexed for MEDLINE]
Free Article
13.

C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.

Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.

Oncol Rep. 2007 Jul;18(1):121-6.

PMID:
17549356
[PubMed - indexed for MEDLINE]
14.

Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.

Castiglione F, Sarotto I, Fontana V, Destefanis M, Venturino A, Ferro S, Cardaropoli S, Orengo MA, Porcile G.

Anticancer Res. 1999 Sep-Oct;19(5C):4555-63.

PMID:
10650810
[PubMed - indexed for MEDLINE]
15.

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer.

Yamashita H, Toyama T, Nishio M, Ando Y, Hamaguchi M, Zhang Z, Kobayashi S, Fujii Y, Iwase H.

Breast Cancer Res. 2006;8(4):R48.

PMID:
16869955
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.

Malamou-Mitsi V, Gogas H, Dafni U, Bourli A, Fillipidis T, Sotiropoulou M, Vlachodimitropoulos D, Papadopoulos S, Tzaida O, Kafiri G, Kyriakou V, Markaki S, Papaspyrou I, Karagianni E, Pavlakis K, Toliou T, Scopa C, Papakostas P, Bafaloukos D, Christodoulou C, Fountzilas G.

Ann Oncol. 2006 Oct;17(10):1504-11. Epub 2006 Sep 12.

PMID:
16968874
[PubMed - indexed for MEDLINE]
Free Article
17.

SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.

Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS.

Am J Surg Pathol. 2008 Oct;32(10):1523-31. doi: 10.1097/PAS.0b013e31816b6478.

PMID:
18724249
[PubMed - indexed for MEDLINE]
18.

Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.

Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR, Ghosh N, Trivedi TI.

Ann Surg Oncol. 2000 May;7(4):305-11.

PMID:
10819372
[PubMed - indexed for MEDLINE]
19.

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM.

Cancer. 2003 Feb 1;97(3):545-53.

PMID:
12548595
[PubMed - indexed for MEDLINE]
Free Article
20.

Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

Hiraike H, Wada-Hiraike O, Nakagawa S, Saji S, Maeda D, Miyamoto Y, Sone K, Tanikawa M, Oda K, Nakagawa K, Yano T, Fukayama M, Taketani Y.

Exp Ther Med. 2011 Nov;2(6):1105-1109. Epub 2011 Aug 12.

PMID:
22977628
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk